Serum creatinine and serum cystatin C as an index of muscle ... : Current Opinion in Nephrology and Hypertension (original) (raw)

DIAGNOSTICS AND TECHNIQUES: Edited by Maarten W. Taal

aNew York University Grossman School of Medicine, New York, New York

bTufts Medical Center, Tufts University, Boston, Massachusetts, USA

Correspondence to Shoshana H. Ballew, NYU Grossman School of Medicine, 227 E30th St, New York, NY 10016, USA. E-mail: [email protected]

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.co-nephrolhypertens.com).

Abstract

Purpose of review

Serum creatinine reflects both muscle mass and kidney function. Serum cystatin C has recently been recommended as an additional marker for estimating kidney function, and use of both markers together may provide an index of muscle mass. This review aims to describe the biological basis for and recent research examining the relationship of these markers to muscle mass in a range of adult populations and settings.

Recent findings

This review identified 67 studies, 50 of which had direct measures of muscle mass, and almost all found relationships between serum creatinine and cystatin C and muscle mass and related outcomes. Most studies have been performed in older adults, but similar associations were found in general populations as well as in subgroups with cancer, chronic kidney disease (CKD), and other morbid conditions. Creatinine to cystatin C ratio was the measure examined the most often, but other measures showed similar associations across studies.

Summary

Measures of serum creatinine and cystatin C together can be an index of muscle mass. They are simple and reliable measures that can be used in clinical practice and research. Further study is needed to determine actionable threshold values for each measure and clinical utility of testing and intervention.

Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.